Read More 1 minute read Analyst Ratings News Price Target Reiteration JMP Securities Reiterates Market Outperform on Guidewire Software, Maintains $95 Price Target By Benzinga Newsdesk March 7, 8:23 AM JMP Securities analyst Joe Goodwin reiterates Guidewire Software (NYSE:GWRE) with a Market Outperform and maintains $95 price target. GWRE
Read More 1 minute read Analyst Ratings News Price Target Reiteration JMP Securities Reiterates Market Outperform on Cytokinetics, Maintains $71 Price Target By Benzinga Newsdesk March 7, 8:19 AM JMP Securities analyst Jason Butler reiterates Cytokinetics (NASDAQ:CYTK) with a Market Outperform and maintains $71 price target. CYTK
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Day One Biopharmaceutical, Maintains $45 Price Target By Benzinga Newsdesk March 7, 7:08 AM HC Wainwright & Co. analyst Andres Maldonado reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains $45 price target. DAWN
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Stoke Therapeutics, Maintains $35 Price Target By Benzinga Newsdesk March 7, 7:07 AM HC Wainwright & Co. analyst Andrew Fein reiterates Stoke Therapeutics (NASDAQ:STOK) with a Buy and maintains $35 price target. STOK
Read More 1 minute read Analyst Ratings News Price Target Reiteration EF Hutton Reiterates Buy on Amprius Technologies, Maintains $14 Price Target By Benzinga Newsdesk March 7, 6:57 AM EF Hutton analyst Chip Moore reiterates Amprius Technologies (NYSE:AMPX) with a Buy and maintains $14 price target. AMPX
Read More 1 minute read Analyst Color Analyst Ratings M&A News Price Target Reiteration Tech Qualtrics Could Bag A Higher Takeover Premium, Analyst Says Post Offer From Silver Lake & Canada Pension Plan By Anusuya Lahiri March 7, 6:48 AM Piper Sandler analyst Brent Bracelin maintains Qualtrics International Inc (NASDAQ:XM) with an Overweight, raising the price target from $16 to $18.15. On… SAP
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Riot Platforms, Maintains $9 Price Target By Benzinga Newsdesk March 7, 6:37 AM Needham analyst John Todaro reiterates Riot Platforms (NASDAQ:RIOT) with a Buy and maintains $9 price target. RIOT
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Ciena, Maintains $70 Price Target By Benzinga Newsdesk March 7, 6:36 AM Needham analyst Alex Henderson reiterates Ciena (NYSE:CIEN) with a Buy and maintains $70 price target. CIEN
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on SEMrush Hldgs, Maintains $20 Price Target By Benzinga Newsdesk March 7, 6:34 AM Needham analyst Scott Berg reiterates SEMrush Hldgs (NYSE:SEMR) with a Buy and maintains $20 price target. SEMR
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on RxSight, Maintains $22 Price Target By Benzinga Newsdesk March 7, 6:30 AM Needham analyst David Saxon reiterates RxSight (NASDAQ:RXST) with a Buy and maintains $22 price target. RXST